Titlebook: Quasiconformal Mappings and Analysis; A Collection of Pape Peter Duren,Juha Heinonen,Bruce Palka Book 1998 Springer Science+Business Media

萬圣節(jié)

書目名稱Quasiconformal Mappings and Analysis影響因子(影響力)




書目名稱Quasiconformal Mappings and Analysis影響因子(影響力)學科排名




書目名稱Quasiconformal Mappings and Analysis網(wǎng)絡公開度




書目名稱Quasiconformal Mappings and Analysis網(wǎng)絡公開度學科排名




書目名稱Quasiconformal Mappings and Analysis被引頻次




書目名稱Quasiconformal Mappings and Analysis被引頻次學科排名




書目名稱Quasiconformal Mappings and Analysis年度引用




書目名稱Quasiconformal Mappings and Analysis年度引用學科排名




書目名稱Quasiconformal Mappings and Analysis讀者反饋




書目名稱Quasiconformal Mappings and Analysis讀者反饋學科排名

INERT

Old and New on the Quasihyperbolic Metric,e that this metric plays an important role in the famous extension theorem of Jones [J1] for functions in BMO and that this metric has by now become a standard tool in the study of quasiconformal mappings.

Charitable

Peter Duren,Juha Heinonen,Brad Osgood,Bruce Palka such as angina or hypertension. This necessarily leads to some overlap, but I have not tried to produce a uniformity of view, but have been content with Chairman Mao ‘to let a hundred flowers bloom‘. I am grateful to my cardiological colleague, Professor A. John Camm for his help and advice on current cardio978-0-412-26540-2978-1-4899-3294-5

堅毅

內(nèi)部

Peter Duren,Juha Heinonen,Brad Osgood,Bruce Palka synthesize them on a large scale, and although for a time much of the world’s supply was derived from coral polyps of the . genus, it was not until the early 1970s that fully synthetic methods were availiable for the manufacture of prostaglandins [1].

Kidney-Failure

Kari Astalace demonstrating that specific subpopulations of alcoholic patients experience satisfactory benefit from currently available treatments. Today we have two medications for relapse prevention on the market – acamprosate and naltrexone. Although, currently, only a minority of alcoholic patients benefit

清洗

Clifford J. Earle,Li Zhongce demonstrating that specific subpopulations of alcoholic patients experience satisfactory benefit from currently available treatments. Today we have two medications for relapse prevention on the market – acamprosate and naltrexone. Although, currently, only a minority of alcoholic patients benefit

Hearten

Tadeusz Iwaniecce demonstrating that specific subpopulations of alcoholic patients experience satisfactory benefit from currently available treatments. Today we have two medications for relapse prevention on the market – acamprosate and naltrexone. Although, currently, only a minority of alcoholic patients benefit

Iniquitous

Brad Osgoodce demonstrating that specific subpopulations of alcoholic patients experience satisfactory benefit from currently available treatments. Today we have two medications for relapse prevention on the market – acamprosate and naltrexone. Although, currently, only a minority of alcoholic patients benefit

Suggestions

Ch. Pommerenke,S. Rohdece demonstrating that specific subpopulations of alcoholic patients experience satisfactory benefit from currently available treatments. Today we have two medications for relapse prevention on the market – acamprosate and naltrexone. Although, currently, only a minority of alcoholic patients benefit